Skip to main content

1 Result(s)

within M Pineda-Roman Remove this filter

and

  1. No Access

    Article

    VTD combination therapy with bortezomib–thalidomide–dexamethasone is highly effective in advanced and refractory multiple myeloma

    Bortezomib (V) was combined with thalidomide (T) and dexamethasone (D) in a phase I/II trial to determine dose-limiting toxicities (DLT's) and clinical activity of the VTD regimen in 85 patients with advanced ...

    M Pineda-Roman, M Zangari, F van Rhee, E Anaissie, J Szymonifka, A Hoering… in Leukemia (2008)